Cravings as a mediator and moderator of drinking outcomes in the COMBINE study

Addiction

Volumn 108, Issue 10, 2013, Pages 1737-1744

  Subbaraman, Meenakshi Sabina ^a,b,c   Lendle, Samuel ^a   van der Laan, Mark ^a   Kaskutas, Lee Ann ^a,b   Ahern, Jennifer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ALCOHOL RESEARCH GROUP   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Alcoholism treatment; Behavioral intervention; Cravings; Mediators; Moderators; Naltrexone

Indexed keywords

DRUGS USED IN THE TREATMENT OF ADDICTION; NALTREXONE; NARCOTIC ANTAGONIST;

ALCOHOL ABSTINENCE; ALCOHOLISM; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; HUMAN; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; ALCOHOLISM TREATMENT; ARTICLE; BEHAVIORAL INTERVENTION; CONTROLLED CLINICAL TRIAL; CRAVINGS; MEDIATORS; METHODOLOGY; MODERATORS; PSYCHOLOGICAL ASPECT; STATISTICS;

ALCOHOL ABSTINENCE; ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLISM; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; QUESTIONNAIRES; TREATMENT OUTCOME;

ALCOHOLISM TREATMENT; BEHAVIORAL INTERVENTION; CRAVINGS; MEDIATORS; MODERATORS; NALTREXONE;

EID: 84884193463     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12238     Document Type: Article

References (43)

1. Anton R. F., Moak D. H., Waid L. R., Latham P. K., Malcolm R. J., Dias J. K. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 1999; 156: 1758-1764.
2. Heilig M., Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 2006; 111: 855-876.
3. Weiss R., Kueppenbender K. Combining psychosocial treatment with pharmacotherapy for alcohol dependence. J Clin Psychopharmacol 2006; 26: S37-42.
4. COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence-the COMBINE study: a randomized controlled trial. JAMA 2006; 295: 2003-2017.
5. Buehringer G., Pfeiffer-Gerschel T. Combine and match: the final blow for large-scale black box randomized controlled trials. Addiction 2008; 103: 708-710.
6. Bergmark A. On treatment mechanisms-what can we learn from the COMBINE study? Addiction 2008; 103: 703-705.
7. COMBINE Study Research Group. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study. Alcohol Clin Exp Res 2003; 27: 1123-1131.
8. O'Malley S. S., Jaffe A. J., Chang G., Schottenfeld R. S., Meyer R. E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992; 49: 881-887.
9. Volpicelli J., Alterman A., Hayashida M., O'Brien C. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876-880.
10. Volpicelli J., Watson N., King A., Sherman C., O'Brien C. Effect of naltrexone on alcohol high in alcoholics. Am J Psychiatry 1995; 152: 613-615.
11. Jaffe A., Rounsaville B., Chang G., Schottenfeld R., Meyer R., O'Malley S. Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J Consult Clin Psychol 1996; 64: 1044-1053.
12. Monterosso J. R., Flannery B. A., Pettinati H. M., Oslin D. W., Rukstalis M., O'Brien C. P. etal. Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict 2001; 10: 258-268.
13. O'Malley S. S., Jaffe A. J., Chang G., Rode S., Schottenfeld R., Meyer R. E. etal. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 1996; 53: 217-224.
14. Baron R. M., Kenny D. A. The moderator mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations. J Pers Soc Psychol 1986; 51: 1173-1182.
15. Cisler R. A., Kivlahan D. R., Donovan D., Mattson M. E. Assessing nondrinking outcomes in combined pharmacotherapy and psychotherapy clinical trials for the treatment of alcohol dependence. J Stud Alcohol 2005; 15: 110-118.
16. Addolorato G., Leggio L., Abenavoli L., Gasbarrini G. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 2005; 30: 1209-1224.
17. Witkiewitz K., Bowen S., Donovan D. M. Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence. J Consult Clin Psychol 2011; 79: 54-63.
18. Meyer R. E. Craving: what can be done to bring the insights of neuroscience, behavioral science and clinical science into synchrony. Addiction 2000; 95: S219-S227.
19. Bottlender M., Soyka M. Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment. Alcohol Alcohol 2004; 39: 357-361.
20. Anton R., Moak D., Latham P. The obsessive compulsive drinking scale-a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry 1996; 53: 225-231.
21. van der Laan M., Rose S. Targeted Learning: Causal Inference for Observational and Experimental Data, 1st edn. New York: Springer; 2011.
22. Gruber S., van der Laan M. tmle: Targeted Maximum Likelihood Estimation of Point Treatment Effects. R package version 1.1.1 [computer program]. 2011.
23. Lendle S. D., van der Laan M. J. Identification and efficient estimation of the natural direct effect among the untreated. UC Berkeley Division of Biostatistics Working Paper Series. 2011.
24. van der Laan M. J., Polley E. C., Hubbard A. E. Super learner. Stat Appl Genet Mol Biol 2007; 6: 1-21.
25. Venables W. N., Ripley B. D. Modern Applied Statistics with S, 4th edn. New York: Springer; 2002.
26. Hastie T. J., Tibshirani R. J. Generalized Additive Models. Boca Raton, FL: Chapman & Hall; 1990.
27. Friedman J. H. Greedy function approximation: a gradient boosting machine. Ann Stat 2001; 29: 1189-1232.
28. Zou H., Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc B 2005; 67: 301-320.
29. Kooperberg C. polspline: Polynomial spline routines [computer program]. Version R package version 1.1.4. 2009.
30. Breiman L. Random forests. Mach Learn 2001; 45: 5-32.
31. Gelman A., Su Y-S. arm: Data analysis using regression and multilevel/hierarchical models [computer program]. Version R package version 1.3-022010. 2010.
32. Meyer D., Dimitriadou E., Hornik K., Weingessel A., Leisch F. e1071: Misc functions of the Department of Statistics (e1071) [computer program]. Version R package version 1.5-222009. 2009.
33. Neugebauer R. S. DSA: Data-adaptive estimation with cross-validation and the D/S/A algorithm [computer program]. Version R package version 3.1.32009. 2009.
34. Petersen M., Sinisi S., van der Laan M. Estimation of direct causal effects. Epidemiology 2006; 17: 276-284.
35. Spanagel R., Zieglgansberger W. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 1997; 18: 54-59.
36. Ray L., Hutchison K. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response-a double-blind placebo-controlled study. Arch Gen Psychiatry 2007; 64: 1069-1077.
37. Monti P. M., Rohsenow D. J., Hutchison K. E. etal. Naltrexone's effect on cue-elicit craving among alcoholics in treatment. Alcohol Clin Exp Res 1999; 23: 1386-1394.
38. Kenna G. A., McGeary J. E., Swift R. M. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1. Am J Health Syst Pharm 2004; 61: 2272-2279.
39. Anton R., Moak D., Latham P., Waid R., Myrick H., Voronin K. etal. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol 2005; 25: 349-357.
40. Torgerson D. J., Sibbald B. Understanding controlled trials-what is a patient preference trial? BMJ 1998; 316: 360-360.
41. Hubbard A., Ahern J., Fleischer N. L., van der Laan M., Lippman S. A., Jewell N. etal. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology 2010; 21: 467-474.
42. Kranzler H. R., Mulgrew C. L., Modesto-Lowe V., Burleson J. A. Validity of the Obsessive Compulsive Drinking Scale (OCDS): does craving predict drinking behavior? Alcohol Clin Exp Res 1999; 23: 108-114.
43. Donovan D., Kivlahan D., Doyle S., Longabaugh R., Greenfield S. Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study. Addiction 2006; 101: 1696-1704.